Mainstream

Trevi Therapeutics outlines $204M cash runway into 2029 as Phase III programs advance following positive CORAL data

Trevi Therapeutics outlines $204M cash runway into 2029 as Phase III programs advance following positive CORAL data

Post ContenttrviRead More

You might also be interested in reading Crypto Mining Made Easy: 3 Gamified Apps You Can’t Miss.

August 8, 2025
In Mainstream